Anne C. Chiang, an associate professor of medical oncology at Yale University, shares her expertise on small cell lung cancer (SCLC). She discusses the alarming prevalence tied to smoking and symptoms that can lead to misdiagnosis. Chiang highlights recent advancements, including immunotherapy from the Adriatic trial, which shows promise for limited-stage SCLC. Additionally, she emphasizes the vital role of palliative care and clinical trials, advocating for tailored treatments that improve outcomes for patients facing this challenging disease.
